The Duke Center for Precision Health (CPH), part of the Duke Clinical & Translational Science Institute (CTSI), and the Duke School of Medicine (SOM) Precision Genomics Collaboratory (PGC), are pleased to announce pilot grants with the goal of advancing genomic science at Duke. This request for proposal (RFP) is open to all Duke SOM faculty and is focused on projects that leverage and enhance the OneDukeGen study infrastructure.
OneDukeGen is a genomic sequencing and biorepository project that is part of the Duke-nference partnership. The study is performing genetic sequencing on ~150,000 Duke patients across multiple diseases and return of genetic test results to applicable participants. Enrollment began in August 2023. The study is part of a 10-year academic-industry partnership between Duke Health and healthcare analytics company nference that is creating a secure, de-identified analytics platform rich with multi-modal data to support research and innovation in both the academic and commercial healthcare sectors.
Clinical data currently being collected on all OneDukeGen participants consists of electronic health record (EHR) data, and biospecimen collection includes DNA for all participants and plasma, RNA and whole blood on a subset. Ongoing areas of study include (but are not limited to) cardiovascular, oncology, neurology and others.
The goal of these pilot grants is to enhance the OneDukeGen infrastructure. Any generated data and/or biospecimens would be shared as part of the OneDukeGen study.
Deadline: Sep. 9, 2024